Home > Balance Sheet > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Capital Work in Progress

    Back to Balance Sheet
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹47 Cr₹5.97 Cr₹3.62 Cr₹3.16 Cr₹65 Cr

What is the latest Capital Work in Progress ratio of KILITCH DRUGS (INDIA) ?

The latest Capital Work in Progress ratio of KILITCH DRUGS (INDIA) is ₹47 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹47 Cr
Mar2024₹5.97 Cr
Mar2023₹3.62 Cr
Mar2022₹3.16 Cr
Mar2021₹65 Cr

How is Capital Work in Progress of KILITCH DRUGS (INDIA) Trending?

Years Capital Work in Progress % Change
Mar2025 ₹47 Cr
692.88
Mar2024 ₹5.97 Cr
64.82
Mar2023 ₹3.62 Cr
14.49
Mar2022 ₹3.16 Cr
-95.17
Mar2021 ₹65 Cr -

Compare Capital Work in Progress of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹464.3 Cr -4.5% -16.7% -25.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,050.0 Cr 1.3% -4.5% -0% Stock Analytics
DIVIS LABORATORIES ₹158,157.0 Cr 1.7% -5.9% 3.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹138,531.0 Cr 2.6% -5% 25.5% Stock Analytics
DR REDDYS LABORATORIES ₹101,190.0 Cr -0.4% -7% 3.6% Stock Analytics
CIPLA ₹98,892.8 Cr 2.6% -7.4% -16.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-4.5%

-16.7%

-25.4%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses